Praxis Precision Medicines, Inc. (PRAX)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$1.39B
Stockholders' Equity
$1.34B
Cash & Equivalents
$474.8M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Praxis Precision Medicines, Inc. reported net income of -$83.7M and total assets of $1.39B. Every figure below is taken directly from Praxis Precision Medicines, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2022–FY2025 · as reported

$8.6M-$147.4M-$303.3M
FY2022FY2023FY2024FY2025
Revenue$0Net income-$303.3M
FY2022 revenue
$0
FY2025 revenue
$0

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$0-$303.3M
FY2024$8.6M-$182.8M
FY2023$2.4M-$123.3M
FY2022$0-$214.0M
FY2021—-$167.1M
FY2020—-$61.8M
FY2019—-$35.5M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KAug 6, 2026on EDGAR ↗
10-QAug 6, 2026on EDGAR ↗
8-KJul 7, 2026on EDGAR ↗
8-KJul 2, 2026on EDGAR ↗
8-KJun 29, 2026on EDGAR ↗
8-KJun 22, 2026on EDGAR ↗
8-KJun 12, 2026on EDGAR ↗
8-KJun 1, 2026on EDGAR ↗
8-KMay 7, 2026on EDGAR ↗
10-QMay 7, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$1.39Bsource ↗
Stockholders’ Equity$1.34Bsource ↗
Cash & Equivalents$474.8Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue—source ↗
Net Income-$83.7Msource ↗
Operating Income-$96.9Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$69.4Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-2.87source ↗
EPS (basic)$-2.87source ↗
Shares Outstanding27.9Msource ↗
Cash from Operations-$77.5Msource ↗
Cash from Financing$4.6Msource ↗
Cash from Investing$11.0Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
12
Net shares
-11.6K

Restatement history

Point-in-time

No material restatements detected across 177 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches PRAX’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PRAX

MCP tool: get_sec_fundamentals ticker=PRAX

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PRAX/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=PRAX as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/PRAX/history

MCP tool: get_fundamentals_history ticker=PRAX

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/PRAX

MCP tool: get_financial_health ticker=PRAX

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.